complaint might affect the ability of ED clinicians
to prescribe drugs, such as in situations of
life-threatening trauma or cardiac arrest. These
situations may have more close correlations with
dose omissions, rather than pharmacist
intervention. Furthermore, situation of admission
may also more significantly affect a total length of
inpatient stay.
References
1 Gerlach O et al. Deterioration
of Parkinson’s disease during
hospitization: Survey of 684
Patients. BMC Neurology
2012:12:13.
2 Guttman M et al. Parkinsonism
in Ontario : Comorbidity
associated with hospitalization
in a large cohort. Mov Disord
2003;17:45–54.
3 Wood B et al. Incidence and
prediction of falls in Parkinson’s
disease : a prospective
multidisciplinary study. J
Neurol Neurosurg Psychiatry
2001;72:721–5.
4 Haddad S et al. Prognostic
factors associated with short-
term decompensation of sepsis
in the emergency department.
Acad Emerg Med 2014;21(5).
5 Fernandez H, Lapane L.
Predictors of mortality among
nursing home residents with a
Conclusions
Pharmacist intervention was associated with a
statistically lower number of omissions of APMs
while in the ED. This intervention was associated
with a lower incidence of PD-related deterioration
in symptoms while in the department.
Furthermore, as the interventions involved early
medicines reconciliation, supply and handover of
care, beneficial effects on dose omissions were
observed on base ward level also. These results also clearly demonstrate the
potential deficiencies of EDs in reconciling and
continuing chronic therapies in the acute setting.
Readily available clinical pharmacists are an ideal
choice in taking on this responsibility and taking
pressure off ED clinicians, as well as yielding time
and efficiency savings on base ward level.
The relatively small amount of data collected
makes it difficult to comment on conclusions
around an effect on length of patient stay. It is
likely that a combination of factors such as age,
co-morbidities and presenting complaint has
impacts on length of stay and outcomes, and
greater numbers of patients would need to be
analysed to draw concrete conclusions.
Further study is required in exploring clinical
pharmacy services within EDs on other high risk
patient profiles, to determine if similar benefits
can be identified.
diagnosis of Parkinson’s disease.
Med Sci Monit 2002;8:241–6.
6 Parkinsons Disease Society.
Emergency management
of patients with Parkinsons.
www.parkinsons.org.uk/
professionals/resources/
emergency-management-
patients-parkinsons (accessed
December 2017).
7 National Patient Safety
Association (NPSA). Reducing
harm from omitted and
delayed medication in
hospital. www.nrls.npsa.nhs.
uk alerts/?entryid45=66720
(accessed December 2017).
8 Sin B et al. Implementation of
a 24-hour pharmacy service with
prospective medication review
in the emergency department.
Hosp Pharm 2015;50(2):
134–8.
9 Rothschild J et al. Medication
errors recovered by emergency Acute Hospitals: unwarranted
variations. www.gov.uk/
government/uploads/system/
uploads/attachment_data/
file/499229/Operational_
productivity_A.pdf (accessed
December 2017).
15 Gohil K, Patel C, Sani.
M. Integrating a clinical
pharmacy service in the ED.
Hospital Pharmacy Europe
2016;83, accessed online
10/3/17 from http://www.
hospitalpharmacyeurope.com/
pharmacy -practice/integrating-
clinical-pharmacy-service-ed
16 Henderson K, Gotel U, Hill J.
Using a clinical pharmacist in
the Emergency Department.
EmergMed J 2015;32(12):RCEM
Abstract 045.
17 Magadalinou K, Martin A,
Kessel B. Prescribing medications
in Parkinsons disease (PD) during
acute admissions to a District
department pharmacists. Ann
Emerg Med 2010;55(6):513–21.
10 Stasiak P et al. Detection and
correction of prescription errors
by an emergency department
pharmacy service. CJEM
2014;16(3):193–206.
11 Marconi G, Claudius I. Impact
of an emergency department
pharmacy on medication
omission and delay. Paediatric
Emerg Care 2012;28(1):30–3.
12 Gohil.K. ED and Inpatient
waiting times for higher risk
medical patients. Internal
Audit, Nottingham University
Hospitals;2016.
13 Kaboli P et al. Clinical
pharmacists and inpatient
medical care: a systematic
review. Arch Intern Med
2006;166(9):955–64.
14 Lord Carter of Coles.
Operational productivity and
performance in English NHS
21
HHE 2019 | hospitalhealthcare.com
General Hospital. Parkinsonism
Relat Disord 2006;13:539–40.
18 Skelly R et al. Does a specialist
unit improve outcomes
for hospitalized patients
with Parkinson’s Disease?
Parkinsonism Relat Disord
2014;20:1242–7.
19 Martinez-Ramirez D et al.
Missing dosages and neuroleptic
usage may prolong length of
stay in hospitalized Parkinson’s
disease patients. PLoS ONE
2015;10:e0124356.
20 Skelly R, Brown L, Fogarty
A. Delayed administration of
dopaminergic drugs is not
associated with prolonged
length of stay in hospitalized
patients with Parkinson’s
Disease. Parkinsonism Relat
Disord 2017;35:25–9.